Results: SVR Genotype 1 Low Viral Titre
24 weeks
48 weeks
SVR (%)
41%
51%
53%
61%
n=51
n=71
n=60
n=85
PEGASYSÆRBV 800
PEGASYSÆRBV 1000/1200
PEGASYSÆRBV 800
PEGASYSÆRBV 1000/1200
Previous slide
Next slide
Back to first slide
View graphic version
Notes:
Clearly, for a geno 1 patient the optimal regimen is 48 wks plus standard dose RBVÖreducing duration and/or doseRBV leads to a reduction in efficacy.
Still want to have a p value (not to be shown but to be quoted if asked)